I agree with most of what you said, and to tie it in to my point, once we have revenue and can push all indications forward without fear of dilution, the value of Cytodyn will begin a sustained ascent in valuation. IMO if there is going to be a buyout it would need to be very soon, but I think we are too far apart on what we think the company is worth vs what BP will pay.